Prof. Nicolas Girard, MD, PhD / Pasi A. Jänne, MD, PhD - Making Precision Decisions for Patients With EGFRm NSCLC: Success Strategies With Targeted Options, Potent Combinations, and Emerging Agents

Michelle Kittleson, MD, PhD - Implementing Targeted Therapies in Transthyretin Cardiac Amyloidosis: From Diagnosis to Stabilization

Prof. Sanjay Popat, FRCP, PhD - The Earlier the Better in Lung Cancer: Multispecialty Guidance on Screening, Diagnosis and Management of Resectable NSCLC

Milind Desai, MD, MBA / Anjali Tiku Owens, MD - Fine-Tuning Hypertrophic Cardiomyopathy Care in the CMI Era: Redefining Management for the Modern Heart Failure Specialist

Julie R. Brahmer, MD, MSc, FASCO - Maximizing the Potential and Expanding the Impact of Immunotherapy in Advanced NSCLC

Mohammad AZ Al-Ani, MD, FACC, FSCMR - Moving HCM Excellence Into the Fast Lane: Harnessing Technology to Reconfigure Clinical Workflows in an Academic Medical Center

Sarah Cuddy, MD / Ronald Witteles, MD - Expert Perspectives on Novel Approaches to Therapy for ATTR Cardiac Amyloidosis

Naval Daver, MD, Ghayas Issa, MD - All Rise for Innovation in AML: Processing New Developments With Menin Inhibitors in Challenging AML Subtypes

Professor Kausik Ray - Achieving Goals in Lipid Management: Then and Now

Shervin Assassi, MD, MS - The Evolving Landscape of Fibrosing Interstitial Lung Diseases: Equipping Clinicians to Enhance Patient Care in the Era of Antifibrotic Therapy

Lauren Edgar, DNP, MSN-Ed., RN, FNP - Nursing Strategies in Transthyretin Cardiac Amyloidosis: Targeted Therapies and the Patient Experience

Sagar Lonial, MD, FACP - 4x4 in Multiple Myeloma: Maintaining Momentum for Delivering Innovative Care in Newly Diagnosed and Relapsed Disease

"Prof. Wojciech Jurczak, MD, PhD - Staying on Track Toward Better CLL Outcomes: Delivering Effective Sequential Care Guided by Real-World Experience"

Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs

Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies

Naval Daver, MD - Winning GAMBITS Against AML: Guidance on Advances and Medical Breakthroughs with Innovative Targeted Strategies

Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD - Navigating the Layers of Complexity in R/R B-Cell Cancers: From Clinical Prognosis to Emerging Therapeutic Prospects in CLL/SLL, MCL, and DLBCL

Stephen R. Broderick, MD, MPHS - Integrating Immunotherapy in Resectable NSCLC: How to Move From Complexity Toward Clarity

Catherine Shu, MD, Gavitt Woodard, MD, FACS - Harnessing Precision With EGFR-Targeted Therapy in Resectable NSCLC: Evidence, Cases, and Considerations for Multidisciplinary Patient Care

Gerard A. Silvestri, MD, MS - Facilitating Progress in Early Detection and Intervention in Lung Cancer: Proactive Strategies to Improve Lung Cancer Screening for High-Risk Individuals in VA Healthcare Settings